Skip to main content

Closed

OKUR: OnKure Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-33.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-7695.6×

Current ratio13.78×

OnKure Therapeutics, Inc.

OKURNASDAQ Global Market·USD·Closed

OnKure Therapeutics, Inc.

OKURNASDAQ·USD·Closed

$3.82

−4.50%

$3.82

−$0.18 (4.50%)

52W Range

55thpctl

Volume

0.78×avg

Mkt Cap

52.23MUSD

P/E

-0.9TTM

Div Yield

–ann

52W Range

55thpctl

Volume

0.78×avg

Market Cap

52.23MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings